A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer. (Q37266006)
Jump to navigation
Jump to search
scientific article published on December 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer. |
scientific article published on December 2013 |
Statements
A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer (English)
Michael A Morse
Donna Niedzwiecki
John L Marshall
Christopher Garrett
David Z Chang
Mebea Aklilu
Todd S Crocenzi
David J Cole
Sophie Dessureault
Amy C Hobeika
Takuya Osada
Mark Onaitis
Bryan M Clary
David Hsu
Gayathri R Devi
Anuradha Bulusu
Robert P Annechiarico
Vijaya Chadaram
Timothy M Clay
1 December 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference